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Abstract
Background: Liver transplantation and resection surgery involve a period of ischaemia and reperfusion to
the liver which initiates an inflammatory cascade resulting in liver and remote organ injury. Bucillamine is a
low-molecular-weight thiol antioxidant that is capable of rapidly entering cells.
Methods: The effect of bucillamine was studied in a rat model of liver ischaemia–reperfusion injury with
45 min of partial (70%) liver ischaemia and at 3 and 24 h of reperfusion. Controls included ischaemia-
reperfusion (I/R) only, sham and bucillamine alone (without ischaemia reperfusion). Liver injury was
assessed by serum transaminases (AST and ALT). Sinusoidal blood flow and hepatocyte apoptosis were
measured using intravital microscopy (IVM).
Results: The hepatocellular injury of I/R produced a markedly elevated serum AST which was reduced
with bucillamine (2072.5  511.79 vs. 932  200.8, P < 0.05) at 3 h reperfusion. Bucillamine treatment
with I/R also increased parenchymal blood flow [red blood cell (RBC) velocity 242.66  16.86 vs. 181.11
 17.59, at the end of 3 h of reperfusion) and reduced hepatocyte necrosis/apoptosis at 3 h as well as
24 h (P > 0.001).
Conclusion: Bucillamine reduces the hepatocellular injury of liver ischaemia reperfusion and improves
parenchymal perfusion.
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Introduction
Liver transplantation and liver resection surgery have increased
dramatically as a result of the excellent duration and quality of life
they can offer selected patients with chronic liver disease and liver
cancers. Both procedures involve a period of ischaemia and rep-
erfusion to the liver which initiates an inflammatory cascade
resulting in liver and remote organ injury. When severe these
changes can be fatal.
Reactive oxygen species (ROS) have a central role to play in
ischaemia-reperfusion injury (I/R).1 ROS activate cytokines, mac-
rophages and other components of the inflammatory pathway.2–4
When generated in large amounts, they can also cause direct oxi-
dative damage to the cells through iron-mediated reactions.5 Thiol
donors are antioxidants which can interrupt the redox signalling
pathway and thereby reduce cytokine and macrophage activation.6
In addition, thiol donors can protect against oxidative injury by
replenishing intracellular glutathione and other endogenous thiol
compounds.7
Bucillamine is a low molecular weight thiol donor that is
capable of rapidly entering cells. As an oral formulation it is
marketed in Japan and Korea for the treatment of rheumatoid
arthritis.8
Similar to other cysteine derivatives such as N-acetylcysteine
(NAC), bucillamine has the ability to replenish intracellular
reduced glutathione (GSH).9 These compounds can directly
scavenge peroxides, but less efficiently than the glutathione/
glutathione peroxidase system. Bucillamine preserves a high
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concentration of oxidized glutathione, which may be its primary
action. Bucillamine has two donatable thiol groups and is four-
fold more potent than NAC in preventing I/R injury in in vitro
studies10 and 16-fold more potent in in vivo studies.11
Bucillamine has undergone some preliminary investigations in
experimental studies of I/R. Amersi and colleagues9 studied Buci-
llamine and I/R in a rat model of liver transplantation. Bucil-
lamine decreased liver I/R injury and increased survival after
transplant, with increased levels of GSH in the liver and decreased
levels of oxidized glutathione in both the liver and blood.
In cardiac I/R injury, Horwitz and Sherman10 demonstrated in
isolated rat cardiac myocytes that bucillamine is a potent antioxi-
dant. Bucillamine (125–500 microM) prevented lactate dehydro-
genase (LDH) release in cardiac myocytes exposed to hydrogen
peroxide or a xanthine/xanthine oxidase system. Further, in dogs
subjected to 90 min of coronary artery occlusion and 48 h of
reperfusion, bucillamine, administered during reperfusion,
decreased myocardial infarct size by 41%.9
Liver I/R is known to cause microcirculatory perfusion failure,
activate polymorphonuclear leukocytes and increase leukocyte-
endothelial cell interaction which in turn contribute to hepatocel-
lular damage and liver dysfunction.12–16
The effect of bucillamine in the treatment of liver warm I/R
injury has not been investigated, furthermore its effect on liver
microcirculation is not known. The aim of the present study was
to use a well-described model of liver ischaemia reperfusion
injury to determine the effect of bucillamine administration on
liver function, liver microcirculation and hepatocyte apoptosis.
Materials and methods
Animals and surgical preparation
The study was conducted under a project license from the Home
Office in accordance with the Animals (Scientific Procedures) Act
1986. Male Sprague–Dawley rats, weighing 270–330 g, were used.
Animals were kept in a temperature-controlled environment with
a 12 h light-dark cycle and allowed tap water as well as standard
rat chow pellets ad libitum. Animals were anaesthetized with 4%
isoflurane and maintained with 2.0% isoflurane (Abbott Labora-
tories Ltd, Kent, UK). They were allowed to breathe spontaneously
through a concentric mask connected to an oxygen regulator and
monitored with a pulse oximeter (Ohmeda biox 3740 pulse
oximeter; Ohmeda, Louisville, KY, USA).
Polyethylene catheters (Portex 2 Fr; Portex, Kent, UK) were
inserted into the carotid artery (right or left) for monitoring of
mean arterial blood pressure and the right jugular vein for admin-
istering normal saline to compensate for intra-operative fluid loss
(1 ml/100 g body weight/hour).
Laparotomy was carried out through a midline incision. The
ligamentous attachments of the liver were cut and the liver
exposed. All animals were administered heparin 20 units/kg.
Partial hepatic ischaemia of the left lateral and median lobes (70%
of liver) was induced by clamping the corresponding vascular
pedicle with an atraumatic microvascular clamp for 45 min. This
model prevents splanchnic congestion by allowing flow through
the remaining liver.17,18 Animals were randomly allocated to the
following groups:
Experimental groups (n = 6 in each group)
• Group 1 – Sham: These animals underwent laparotomy and
liver mobilization under general anaesthesia but without clamp-
ing of the liver vascular pedicle.
• Group 2 – IR: 45 min of partial hepatic ischemia followed by 3 h
of reperfusion.
• Group 3 – Bucillamine [15 mg/kg/h intravenously (i.v.)] + IR.
• Group 4 – SB: sham + bucillamine (15 mg/kg/h i.v.).
• Group 5 – I/R: 24–45 min of ischaemia followed by 24 h of
reperfusion.
• Group6 – B: 24-45 min of ischaemia + bucillamine 15 mg/kg/h
i.v. followed by 24 h of reperfusion.
The bucillamine group were administered a bucillamine infu-
sion (15 mg/kg/h) over the operative period (For 10 min prior to
ischaemia, during the period of ischaemia and for 3 h in the
reperfusion period). Bucillamine was supplied by Santen pharma-
ceuticals, Osaka, Japan. Animals in the sham and I/R groups were
given equivalent volumes of saline. Temperature of the animal was
monitored and maintained at 36–38°C by means of a heating pad
(Harvard Apparatus Ltd, Kent, UK).
Intravital microscopy
Intravital microscopy (IVM) was used to assess the perfusional
changes associated with I/R and possible alterations with Bucil-
lamine administration. The left lobe of the liver was gently
mobilized and placed over a specially designed platform (Nikon
microscope, Nikon, Tokyo, Japan). The surface of the liver was
moistened with normal saline and visualized through a coverslip.
Images (25 pictures/s) from the microscope were recorded using
a camera (JVC video camera; JVC, Osaka, Japan) directly on to a
computer for further analysis. Off-line microcirculatory analysis
was performed from recorded images to measure red blood cell
(RBC) velocity and sinusoidal diameter using Lucia G software
(Laboratory Universal Computer Image Analysis; Nikon).
RBCs (from a previously bled rat) were labelled with fluo-
rescein isothiocyanate (FITC) using a technique previously
described19 and labelled RBCs (0.5 ml) were administered via the
jugular vein at 30-min reperfusion. The hepatic microcirculation
was evaluated after 30, 60, 120 and 180 min after reperfusion.
Microcirculatory changes were studied in sinusoids (periportal,
midzonal and pericentral sinusoids) within randomly selected
acini. The following parameters were studied.
Mean RBC velocity
Mean RBC velocity was determined at 40¥ magnification. Ten
sinusoids were randomly selected at each time point in each
animal and RBC velocity was calculated using frame-by-frame
analysis as previously described.20 Mean value was calculated for
each time point.
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Sinusoidal diameter
Sinusoidal diameter was measured in 10 randomly selected
sinusoids at each time point in each animal and the mean was
calculated.
Sinusoidal perfusion
Five randomly chosen non-overlapping rappaport acini were
observed for a minute and recordings made from representative
areas for 2 s with a JVC video camera (JVC TK-C1360B colour
video camera; JVC) (25 frames per second) and stored on the
computer for each time point. Perfusion was established by study-
ing the ratio of perfused to total visible sinusoids after adminis-
tration of FITC-labelled RBC. Sinusoidal perfusion was graded as
continuously perfused (continuous perfusion for >1 min) (Nc) or
interrupted (intermittent perfusion for 1-min period) (Ni) or
non-perfused (Nn). The sinusoidal perfusion index was calculated
as previously described21:
Perfusion index N 0.5 N
N N N
= +
+ +
c i
c i n
 
 and expressed as %
( )
( ) .
Sinusoidal blood flow
Sinusoidal blood flow was calculated as previously decribed.22
Sinusoidal blood Flow Velocity d 2 2= ¥ p¥ ( ) ( )expressed as pl s
Leukocyte parameters
Leukocyte–endothelial interactions were studied by labelling
leukocytes in vivo using administering rhodamine 6G (Sigma,
Rodermark, Germany) 0.3 mg/kg intra-arterially22 at 150 min
post-reperfusion. Ten randomly chosen post-sinusoidal venules
were visualized for 20 s each under green filtered light. The
number of adherent leukocytes were counted and expressed as
cells per mm2 of endothelial surface (length of observed vessel
length ¥ diameter ¥ p = adherent cells per mm2) as previously
described.22,23 Leukocytes adherence was measured as adherent
leukocytes per mm2 of liver tissue.
Detection of hepatocellular death in vivo
Propidium iodide fluorescent dye stains the nuclei of cells that are
lethally damaged.24 Propidium iodide (0.05 mg/kg) was injected
after 3 h of reperfusion. The dead nuclei were identified as those
stained with propidium iodide. These were counted in each high
power field and an average value was taken for each subject after
studying at least five high power fields (studying all regions of the
acini). The area in each high power field was calculated using Lucia
G software (Laboratory Universal Computer Image Analysis;
Nikon) and results were expressed as number of dead cells per
mm2.
At the end of the experiment animals were killed by exsan-
guinations. Serum and plasma samples were collected by spinning
the blood at 400 g for 10 min and stored in aliquots of 0.2 ml
at -80°C. A sample of liver tissue was taken from the left lobe and
stored in formalin for histopathology.
In the recovery experiments (Group 5 and 6), the neck line
was removed after the period of infusion (3 h reperfusion) and
the neck wound closed using a 4-0 Vicryl continuous suture
(Ethicon, Somerville, NJ, USA). The animals were recovered,
administered adequate analgesia (Buprenorphine 0.15 mg/kg sub-
cutaneously) and kept in a temperature controlled environment
with a 12 h light-dark cycle and allowed tap water as well as
standard rat chow pellets ad libitum. After 24 h, the animals were
re-anaesthetized with 4% isoflurane and maintained with 2.0%
isoflurane (Abbott Laboratories Ltd.). They were allowed to
breathe spontaneously through a concentric mask connected to an
oxygen regulator and monitored with a pulse oximeter (Ohmeda
biox 3740 pulse oximeter; Ohmeda). The right carotid artery was
cannulated with a polyethylene catheter (0.40-mm inner diameter;
Portex) for administering fluorochromes. The abdomen was
re-opened through the previous incision. The left lobe of liver was
mobilized gently after dividing filmy adhesions that had formed
after previous laparotomy and put under the IVM for visualization.
It was difficult to mobilize the liver on account of adhesions and
tissue oedema as compared with 3 h reperfusion groups and in vivo
hepatocellular death was the only parameter studied. Experiments
were terminated and samples collected as above.
Liver function
Blood was sampled at the end of the procedure from the IVC 3 h
post-reperfusion and centrifuged at 400 g for 10 min. Serum was
analysed on an autoanalyser (Hitachi 747; Hitachi, Tokyo, Japan)
using commercially available kits (Boehringer Mannheim, Lewes,
East Sussex, UK) for serum aspartate transaminase and serum
alanine transaminase.
Histological investigations
At the end of the experiment, samples of liver were taken from the
left lobe, fixed in 10% neutral buffered formalin and embedded in
paraffin. Paraffin sections 4 mm thick were cut using a microtome
and mounted on slides for haematoxylin and eosin staining.
Assessment of liver injury was performed by a Consultant
pathologist who was blinded to the study groups, using a scoring
system devised by Suzuki et al.25 (Table 1).
Table 1 Suzuki's criteria
Numerical
assessment
Congestion Vacuolation Necrosis
0 None None None
1 Minimal Minimal Single cell
2 Mild Mild <30%
3 Moderate Moderate <60%
4 Severe Severe >60%
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Data collection and statistics
Data were continuously collected for oxygen saturation, blood
pressure and mean arterial pressure (MAP). Averages for 1 min
were calculated at 30, 60, 120 and 180 min post-reperfusion. Data
are expressed as mean standard error of mean (SEM). Analysis
of data was carried out using SPSS 14.0 (SPSS Inc., Chicago, IL,
USA). Differences in data between groups were assessed using
one-way anova with Bonferroni’s post-hoc test. Data were con-
sidered statistically significant if P < 0.05.
Results
There were no procedure-related deaths in either group. The
model was haemodynamically stable (Fig. 1a–b). There was a sta-
tistically significant transient fall in oxygen saturation immedi-
ately after reperfusion which was reduced using Bucillamine
therapy (Fig. 1c).
Biochemistry
Transaminases were grossly elevated after I/R. The bucillamine I/R
group had lower AST and ALT than the I/R group [(AST 932 
200.81 vs. 2072.5  511.79, P < 0.05), (ALT 861.4  262.63 vs.
2079.3  322.33, P < 0.05)] (Fig. 2a–b). The AST as well as ALT
were less raised in the B24 group as compared with the IR24
group, although this was statistically non-significant (AST, 3053
1322.06 vs. 3379  1501.51) (ALT, 1611  588.12 vs. 1740.67 
723.11) (Fig. 2c–d).
Intravital microscopy
We did not find any difference in the perfusion, leukocyte adhe-
sion, in the different sinusoidal regions (periportal, midzonal and
pericentral sinusoids) within the same group of animals. RBC
velocity was taken as an average over the entire visible length
of the sinusoid. Hepatocyte apoptosis/necrosis was more severe in
the pericentral region and we studied all the regions to calculate
the number of non-viable nuclei.
RBC velocity
RBC velocity remained stable in the Sham group over the duration
of the experiment. I/R produced a gradual fall in RBC velocity from
baseline which was significant vs. Sham-operated animals at 120
and 180 min (P < 0.001). In the bucillamine I/R group, the initial
fall in the RBC velocity at 60 min post-reperfusion was similar to
I/R (299.71 18.15 vs. 244 15.49, not significant) but after this
the velocities remained steady for the subsequent 2 h duration.
Bucillamine significantly increased the RBC velocity compared
with the IR alone group as demonstrated in Fig. 3a. Velocities were
lower in the SB group as compared with the sham group, but there
was no change in the velocities over time (Fig. 3a).
Sinusoidal diameter
There was no statistically significant difference in the sinusoidal
diameter in the I/R or bucillamine I/R groups (Fig. 3b).
Sinusoidal perfusion index
The sinusoidal perfusion index was lower in the I/R group as
compared with SB and sham groups at all time points. Bucil-
lamine therapy with I/R increased the sinusoidal perfusion
although values were not statistically significant (Fig. 3c).
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Sinusoidal blood flow
I/R reduced sinusoidal blood flow over the reperfusion period.
Bucillamine with I/R maintained the sinusoidal blood flow, after
an initial fall, although, none of these changes, however, were
statistically significant (Fig. 3d).
Leukocyte adherence in venules and sinusoids
I/R injury was associated with adherence of leukocytes in the
venules. Bucillamine with I/R reduced leukocyte adherence
(385.66  142.69) in the venules; however, this was not statisti-
cally reduced when compared with the I/R group (Fig. 4a). Buci-
llamine given with IR significantly reduced leukocyte adherence in
sinusoids when compared with the IR alone group (29.97 13.81
vs. 97.4  7.49, P < 0.005) (Fig. 4b).
Hepatocellular cell death in vivo
The number of lethally damaged nuclei could be assessed in all of
the animals in 3 h reperfusion groups. I/R produced significant
hepatocellular death (1816  293.09 cells/mm2) which was sig-
nificantly reduced with bucillamine administration at 3-h reper-
fusion (258.48  46.73 cells/mm2, P < 0.001) (Fig. 5a). IVM was
not possible because of oedema and necrosis in one animal in the
IR24 group and was only possible to get partial data in one animal
in the B24 group. Complete data was obtained in five animals in
both groups. There also was statistically significant difference in
the non-viable nuclei between the B24 and IR24 groups (385.37
49.37 vs. 923.98  116.68, P < 0.005). (Fig. 5b)
Histology
I/R injury caused significant periportal congestion with severe
necrosis in zones 2 and 3 (Fig. 6a). The bucillamine I/R group
showed less damage. Portal as well as central venous congestion
was seen but there was no significant spill out into the surround-
ing parenchyma. The only change appeared to be some degenera-
tive changes in the perivenular hepatocytes (Fig. 6b). The SB
group had well-preserved architecture and the sham group
revealed minimal changes (Fig. 6c–d). In the IR24 group, severe
damage with abundant ballooning degeneration and necrosis
was seen which was reduced by bucillamine administration
(Fig. 6e–f).
Discussion
This study has shown for the first time that bucillamine can
reduce the effects of liver warm ischaemia–reperfusion injury.
This is also the first study showing the effect of bucillamine on
liver microcirculation in vivo. The protective effect of bucillamine
was also seen during the late phase of reperfusion injury. The
model of partial liver ischaemia and reperfusion injury used in
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this study is stable, reproducible and avoids splanchnic congestion
found with total liver inflow occlusion.18 Technical manoeuvres
such as performing the laparotomy, mobilization of the liver and
performing IVM did not affect the heart rate, oxygen saturation or
MAP as shown by stable parameters in the sham and the SB
groups. There was a fall in mean arterial pressure after I/R injury
in both the I/R and bucillamine I/R groups which was not statis-
tically significant. Bucillamine administration without I/R has no
effect on the vital parameters or haemodynamic stability of the
animals suggesting that it has no direct effect on systemic or portal
haemodynamics.
IVM has allowed novel insights into hepatic haemodynamics
after I/R and the effect of bucillamine administration. Liver I/R is
known to cause microcirculatory perfusion failure, activate poly-
morphonuclear leukocytes and increase leukocyte-endothelial cell
interaction which in turn contribute to hepatocellular damage
and liver dysfunction.12–16 Bucillamine administration with I/R
was shown to maintain RBC velocity, sinusoidal blood flow and
sinusoidal perfusion in the reperfusion period. It has also been
shown to decrease leukocyte adhesions in venules and decrease
hepatocyte apoptosis/ necrosis.
RBC velocity
In our experiments, there was a gradual drop in the RBC velocity
in the I/R group, whereas the RBC velocity remained stable after
an initial drop in the bucillamine group. This would be consistent
with the scavenging of oxygen free radicals by bucillamine. RBC
mechanical properties play a key role in tissue perfusion.26,27 RBC
velocity can be affected by changes in both aggregability and
deformability of the RBCs, and oxygen free radicals which form as
a result of I/R affect RBC aggregation and deformability.28
Decreased RBC deformability is associated with oxygen free
radical damage during sepsis and is linked to multiorgan failure.29
Pre-treatment with an oxygen free radical scavenger prevents such
adverse changes in deformability.30 RBC aggregation also has an
impact on blood flow mainly in low shear regions.31 In experi-
mental settings, externally generated oxygen free radicals (i.e.
outside RBCs) increase aggregation of RBCs whereas internally
generated oxygen free radicals affect the deformability.32 By scav-
enging oxygen free radicals, bucillamine might be preventing RBC
aggregation and deformability thus maintaining RBC velocity.
After absorption, bucillamine enters the RBCs rapidly and is
carried within the erythrocytes.33–35 This might be of importance
in the beneficial effect of bucillamine.
Sinusoidal perfusion
I/R injury decreased the sinusoidal perfusion which is a known
consequence of severe liver I/R injury12 and results in significant
compromise of hepatic tissue oxygenation and damage and
functional impairment of parenchymal and non-parenchymal
cells.12,14,15 The severity of sinusoidal perfusion failure is propor-
tional to the ischaemia time.12 Bucillamine was shown to reduce
the perfusion abnormality of I/R with a increased sinusoidal per-
fusion. This could be related to its effect on (i RBCs (decreased
aggregability or better maintenance of deformability) and/or (ii)
white blood cell (WBC) adhesions. Sinusoidal perfusion was also
(a) (b) (c)
(d) (e) (f)
Figure 6 Histopathology: H and E Staining 20¥ magnification. (a) ischaemia-reperfusion (I/R) group; (b) bucillamine + I/R; (c) sham; (d) sham
+ bucillamine; (e) IR24 group; (f) B24
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better maintained in the SB group, which although, as mentioned
earlier had lower RBC velocity, had normal liver function, indi-
cating that a combination of better perfusion and maintenance of
RBC velocity would decrease abnormality in liver function.
Sinusoidal diameter
Changes in sinusoidal diameter by constriction of hepatic stellate
cells mediated by endothelin-1 are known to influence the hepatic
perfusion in endotoxaemia.23,33,36 Our results do not suggest such a
role in liver I/R injury. The increase in sinusoidal diameter in the
Sham group from 30 min to 180 min post-reperfusion could be
attributed to the effect of anaesthesia. This would suggest that
there might be a relative decrease in the sinusoidal diameters in
the I/R and bucillamine groups. The sinusoidal dilatation in the
bucillamine group at 30 min could explain the better perfusion
and cytoprotection. Our results also do not suggest primary
vasodilator function for bucillamine as the sinusoidal diameter
did not increase in the SB group.
Sinusoidal blood flow
There was a progressive decrease in sinusoidal blood flow after I/R
injury. Sinusoidal blood flow was maintained after bucillamine
administration. Sinusoidal blood flow is essentially related to the
velocity of flow and diameter and our data on sinusoidal flow are
similar to that for RBC velocity as there was no significant change
in the diameter. The sinusoidal blood flow values were lower
(although not significant as compared with sham) in the SB group
demonstrating that the maintained blood flow in the group who
had I/R with administration of bucillamine was not related to a
direct effect of bucillamine but related to its effect on the inflam-
matory cascade of I/R.
Leukocyte–endothelial interactions
The I/R group showed leukocyte adherence in the sinusoids and
post-sinusoidal venules. Jaeschke et al. first showed that leukocyte
infiltration into liver parenchyma is associated with the develop-
ment of liver I/R injury.23,37 Hepatic I/R induces accumulation,
adherence and extravasation of leukocytes in both sinusoids and
post-sinusoidal venules.13 The increased number of adherent leu-
kocytes in venules, but not in sinusoids, is known to correlate with
the extent of liver dysfunction.13 Leukocyte adherence in venules is
mainly mediated by an increased expression of ICAM-1.14,23,38 Our
study showed a decreased leukocyte adherence in venules with
bucillamine after I/R. Bucillamine is known to scavenge ROS thus
decreasing Kupffer cell and leukocyte activation. Leukocyte adhe-
sion in sinusoids may decrease perfusion of sinusoids.13 However,
although we could show significantly increased adherent sinuso-
ids in the I/R group the number of adherent leukocytes were very
few, which would suggest that the adherent leukocytes are not the
cause of reduced parenchymal perfusion. They might, however, be
contributing to the hepatocellular injury and dysfunction by
release of cytokines and generation of ROS.
Hepatocellular injury/apoptosis
The propidium iodide staining confirmed that there was signifi-
cant hepatocellular necrosis associated with I/R injury in this
model. Bucillamine administration reduced the number of non-
viable nuclei by more than 80%. Liver warm I/R is associated with
necrosis/apoptosis of hepatocytes.39 In liver I/R, oncotic necrosis
and apoptosis share features and mechanisms.39,40 It is suggested
that the ability of a necrotic process to be converted to an apop-
totic one and vice versa illustrates that the pathways in the two
processes could be shared, a phenomenon called necroapopto-
sis.41,42 Irreversible injury in anoxic hepatocytes is precipitated by
an abrupt increase in plasma membrane permeability which
results in uptake of propidium iodide, labelling the non-viable
nuclei.24 This technique has been used to demonstrate non-viable
hepatocytes.24,43,44 This study has shown that with better perfusion
and decreased leukocyte adherence, bucillamine reduces the hepa-
tocyte damage, which could be related to its effect on scavenging
of ROS.
These findings suggest that this agent may prove to be a useful
target in liver protection against I/R injury and could be of clinical
benefit in the field of liver transplantation or liver resection
surgery. In phase I human studies in normal volunteers, bucil-
lamine at doses up to 25 mg/kg/h i.v. for 3 h elicited no serious
drug-related adverse effects33 and would merit a future clinical
study.
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